NDFOS Past Earnings Performance
Past criteria checks 0/6
NDFOS's earnings have been declining at an average annual rate of -10.8%, while the Chemicals industry saw earnings growing at 11.5% annually. Revenues have been declining at an average rate of 3.5% per year.
Key information
-10.8%
Earnings growth rate
-2.5%
EPS growth rate
| Chemicals Industry Growth | 13.9% |
| Revenue growth rate | -3.5% |
| Return on equity | -10.2% |
| Net Margin | -24.1% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
NDFOS Co., Ltd.'s (KOSDAQ:238090) Business Is Yet to Catch Up With Its Share Price
Jun 27
Is NDFOS (KOSDAQ:238090) Using Debt Sensibly?
Apr 09NDFOS Co., Ltd.'s (KOSDAQ:238090) Share Price Could Signal Some Risk
Mar 05Update: NDFOS (KOSDAQ:238090) Stock Gained 53% In The Last Three Years
Mar 16Is NDFOS (KOSDAQ:238090) A Risky Investment?
Feb 17
Here's Why NDFOS's (KOSDAQ:238090) Statutory Earnings Are Arguably Too Conservative
Jan 27What Do The Returns On Capital At NDFOS (KOSDAQ:238090) Tell Us?
Jan 06NDFOS Co., Ltd.'s (KOSDAQ:238090) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Dec 16If You Had Bought NDFOS (KOSDAQ:238090) Shares Three Years Ago You'd Have Earned 101% Returns
Nov 25Revenue & Expenses Breakdown
How NDFOS makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 51,618 | -12,444 | 9,563 | 3,335 |
| 31 Dec 23 | 48,867 | -10,658 | 8,863 | 3,038 |
| 30 Sep 23 | 75,198 | -8,625 | 7,599 | 4,094 |
| 30 Jun 23 | 74,719 | -11,159 | 9,042 | 4,092 |
| 31 Mar 23 | 78,856 | -14,583 | 9,827 | 4,215 |
| 31 Dec 22 | 89,316 | -14,225 | 11,145 | 5,025 |
| 30 Sep 22 | 42,130 | 134 | 11,591 | 4,610 |
| 30 Jun 22 | 58,997 | 6,781 | 11,114 | 5,488 |
| 31 Mar 22 | 65,091 | 14,115 | 10,576 | 5,028 |
| 31 Dec 21 | 63,315 | 13,874 | 9,830 | 4,940 |
| 30 Sep 21 | 68,344 | 2,754 | 9,874 | 5,683 |
| 30 Jun 21 | 68,260 | 7,142 | 8,532 | 6,191 |
| 31 Mar 21 | 61,169 | 18,234 | 7,879 | 7,371 |
| 31 Dec 20 | 62,753 | 7,702 | 8,694 | 5,883 |
| 30 Sep 20 | 89,071 | 20,192 | 9,686 | 5,373 |
| 30 Jun 20 | 83,319 | 2,928 | 10,465 | 3,977 |
| 31 Mar 20 | 86,922 | -11,162 | 10,373 | 2,761 |
| 31 Dec 19 | 84,123 | -624 | 8,630 | 3,157 |
| 30 Sep 19 | 75,100 | -20,657 | 8,507 | 1,735 |
| 30 Jun 19 | 67,048 | -10,288 | 6,831 | 1,462 |
| 31 Mar 19 | 54,308 | -8,089 | 5,462 | 1,488 |
| 31 Dec 18 | 47,758 | -7,858 | 4,531 | 1,760 |
| 31 Dec 17 | 52,344 | 8,072 | 4,512 | 2,521 |
| 31 Dec 15 | 57,458 | 13,758 | 7,128 | 0 |
| 31 Dec 14 | 46,417 | 4,071 | 5,371 | 0 |
| 31 Dec 13 | 24,943 | 335 | 3,301 | 0 |
Quality Earnings: A238090 is currently unprofitable.
Growing Profit Margin: A238090 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A238090 is unprofitable, and losses have increased over the past 5 years at a rate of 10.8% per year.
Accelerating Growth: Unable to compare A238090's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A238090 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-15.1%).
Return on Equity
High ROE: A238090 has a negative Return on Equity (-10.25%), as it is currently unprofitable.